TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light November 26, 2014
TCL Archive NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects November 12, 1976
